Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9532]

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany

How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

New challenges in drug combination and strategies

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

New challenges in drug combination and strategies ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )

Dealing with the aftermath of cancer

Prof Jane Maher - Joint Chief Medical Officer, Macmillan Cancer Support

Dealing with the aftermath of cancer ( Prof Jane Maher - Joint Chief Medical Officer, Macmillan Cancer Support )

Editor's choice for October 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Editor's choice for October 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Targeting N-RAS mutated tumours

Prof Axel Hauschild - University of Kiel, Kiel, Germany

Targeting N-RAS mutated tumours ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

HVEM expression in melanoma metastasis: prognosis correlation

Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France

HVEM expression in melanoma metastasis: prognosis correlation ( Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France )

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

Tackling increasing prevalence of cancer and treatment costs

Dr Vivek Muthu - Chief Health Advisor, The Economist Intelligence Unit

Tackling increasing prevalence of cancer and treatment costs ( Dr Vivek Muthu - Chief Health Advisor, The Economist Intelligence Unit )

Cancer and the workplace

Dr Fiona Adshead - Chief Wellbeing & Public Health Officer, Bupa

Cancer and the workplace ( Dr Fiona Adshead - Chief Wellbeing & Public Health Officer, Bupa )

Preventing cancer in the EU through legislation, education and taxation

John Ryan - Health and Food Safety Directorate General, European Commission

Preventing cancer in the EU through legislation, education and taxation ( John Ryan - Health and Food Safety Directorate General, European Commission )

System reform needed for UK medicine approval

Paul Catchpole - Value and Access Director, The Association of the British...

System reform needed for UK medicine approval ( Paul Catchpole - Value and Access Director, The Association of the British Pharmaceutical Industry )

More from ecancer